Navigation Links
First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

on to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

The brands listed are the registered trademarks of their respective owners.

Contact

Teva Neuroscience
John Shaw, 816-508-5062
john.shaw@tevaneuro.com


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model

Post Your Comments:
(Date:11/6/2009)..., SARASOTA, Fla., Nov. 6 /PRNewswire-FirstCall/ ...nounced that it has signed a definitive agreement ...roprietary medical devices. The Verathon Board of...osing is subject to customary regulatory approvals...roval. The parties expect the closing to be compl...
(Date:11/6/2009)..., PRINCETON, N.J., Nov. 6 /PRNewswire-FirstCall/...DSCI), a provider of advanced wound care products,... results before market on Monday, November 16, 200...me day to discuss the results at 11:00 am EST. Int...ic) or (857) 350-1684 (international), with passco...
(Date:11/6/2009)..., LEXINGTON, Ky., Nov. 6 /PRNewswire-FirstCall/ ... Board: VHGI) confirmed today that the previously ... related assets to Wound Management Technologies, ...ard of Directors and shareholders of VHGI. ,,...he potential stock dividend, royalty stream and ca...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4CorVel Announces Revenues and Earnings 47873 1CorVel Announces Revenues and Earnings 47873 2CorVel Announces Revenues and Earnings 47873 3CorVel Announces Revenues and Earnings 47873 4CorVel Announces Revenues and Earnings 47873 5CorVel Announces Revenues and Earnings 47873 6Leading Sperm Bank Expands Fertility Preservation Services to the Big Apple 47872 1Leading Sperm Bank Expands Fertility Preservation Services to the Big Apple 47872 2DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm 47870 1DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm 47870 2DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm 47870 3
...gs of amylin/leptin synergy and translational Phas... Proceedings of the National Academy of S...O, May 5 Amylin Pharmaceuticals, Inc.,(Nasdaq: A... clinical study,evaluating various dosing combinat...one amylin, and recombinant human leptin (r-metHuL...
...d Improvement in Symptoms Both in the Short and Lo...INGTON, Del., May 5 AstraZeneca (NYSE:,AZN) today...iapine,fumarate) Extended-Release Tablets for the ...eneralized anxiety disorder (GAD) in adult patient...ay at the 161st Annual,Meeting of the American Psy...
Other Medicine Technology:Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity 2Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity 3Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity 4Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity 5New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 2New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 3New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 4New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 5New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 6New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 7New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 8New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 9New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 10New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 11New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 12New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 13New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 14
(Date:11/7/2009)..., HOUSTON, Nov. 7 ...sented Lisa James, Director of Health at the Famil...Distinguished Service today at its semi-annual pol...d Service is the highest honor the AMA House of De... http://www.newscom.com/cgi-bin/prnh/20081209/A...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Calling thi...ociation (AMA), the AMA President J. James Rohack,... physicians from all state and medical specialty s...olicy-making meeting, where health system reform w...com.com/cgi-bin/prnh/20081209/AMALOGO ) ,, "O...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ ...nearing, antichoice extremists are holding the ent...nda. They are demanding that the bill go far beyon... been incorporated into the original bill. In an ...d on early Saturday afternoon, antichoice Democrat...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ ...e House of Representatives to vote for the Stupak-..., "The Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-L... federal law on abortion funding and conscience pr...a Act (H.R. 3962)," they said. ,, The letter wa...
(Date:11/7/2009)... WASHINGTON, Nov. 7 Americans United for Life Act...f the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lip...y federal money from going to abortion in health c...President and CEO Dr. Charmaine Yoest said, "Ameri...Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-...
Breaking Medicine News(10 mins):Health News:AMA Honors Family Violence Prevention Expert 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
...and Men From 46 States and 7 ...,900 participants in this,weekend,s fifth annual A...illion to advance access to care and finding a cur... grants, with millions,more slated to be awarded t...
...OCS, Inc. and,Press Ganey Associates, Inc. today a...eby the companies have combined their best-of-bree...of products for the home,health care industry. The...ient outcomes and financial performance. The first...
...udy finds , SUNDAY, Oct. 7 (HealthDay News) -- Men...fall have a better chance of survival than those d...Norwegian men suggests. , "Summer and autumn month...at this possibility should be studied further," st...
...,transcript of a radio address by President Bush t... important commitment of the Federal government is...health care. Most of these children are,covered by...struggling, we have the State Children,s Health In...
...d to MRI exposure, scientists say , FRIDAY, Oct. 5...a newly identified disease called nephrogenic syst..., U.S. researchers report. , The researchers also ... condition characterized by a thickening and harde...
...vascular disease , , FRIDAY, Oct. 5 (Healt...re having problems achieving or sustaining erectio...tile dysfunction, or impotence, affects more than ...of research ties erectile dysfunction to vascular ...
Other Medicine News:Health News:Fifth Annual Avon Walk for Breast Cancer New York Raises $10.2 Million 2Health News:Fifth Annual Avon Walk for Breast Cancer New York Raises $10.2 Million 3Health News:OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction 2Health News:Prostate Cancer Survival Varies by Season 2Health News:Radio Address by President Bush to the Nation 2Health News:New Kidney Disease Can Be Fatal 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 3
... the functional management of grade I, II, and III...ed aircell, the brace provides focused, pneumatic ...upporting the arm and shoulder. A detachable sling...al arm support and helps to unload the waist strap...
Humeral Stabilizing System (HSS)
Humerus Fracture Brace
Functional Arm Brace
Medicine Products: